Metraipolis › archive › dc_bbbd8bee4706

Reprogramming cancer immunity with next-generation combination therapies — Europe PMC PMID:40950404

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40950404
DOI: 10.3389/fcell.2025.1652047
License (as archived): solo-consultazione
Archived: 2026-11-10T06:50:20.561Z
SHA-256 of the archived text: e1fdb959be790fcbe127c26238dcdc94ce640b767c6ffa61fd999c2241341e1c
Stable URL of this page: https://metraipolis.com/documento/dc_bbbd8bee4706

How to cite

Reprogramming cancer immunity with next-generation combination therapies — Europe PMC PMID:40950404 — Europe PMC (en), https://europepmc.org/article/MED/40950404 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbbd8bee4706 (Metraipolis archive dc_bbbd8bee4706, sha256 e1fdb959be790fcbe127c26238dcdc94ce640b767c6ffa61fd999c2241341e1c)

BibTeX

@misc{dcbbbd8bee4706,
  title = {Reprogramming cancer immunity with next-generation combination therapies — Europe PMC PMID:40950404},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40950404},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbbd8bee4706; sha256 e1fdb959be790fcbe127c26238dcdc94ce640b767c6ffa61fd999c2241341e1c},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40950404. Agents can read the archived copy with the MCP tool read_document.